Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
about
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific RegionPrevalence of symptoms of gastroesopahgeal reflux in a cohort of Saudi Arabians: a study of 1265 subjects.Psychometric validation of the Dutch translation of the quality of life in reflux and dyspepsia (QOLRAD) questionnaire in patients with gastroesophageal reflux diseaseHeartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease.Impact of gastroesophageal reflux disease on daily life: the Systematic Investigation of Gastrointestinal Diseases in China (SILC) epidemiological study.Online follow-up of individuals with gastroesophageal reflux disease using a patient-reported outcomes instrument: results of an observational study.The value of branded proton pump inhibitors: formulary considerations.The burden of chronic obstructive pulmonary disease among employed adultsComparison of health care resource utilization and costs among patients with GERD on once-daily or twice-daily proton pump inhibitor therapyPersistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients.The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran.Randomised clinical trial: the clinical efficacy and safety of an alginate-antacid (Gaviscon Double Action) versus placebo, for decreasing upper gastrointestinal symptoms in symptomatic gastroesophageal reflux disease (GERD) in ChinaPartial response to proton pump inhibitor therapy for GERD: observational study of patient characteristics, burden of disease, and costs in the USA.Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study.Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis.Enhanced endoscopic imaging and gastroesophageal reflux disease.Systematic review: the burden of disruptive gastro-oesophageal reflux disease on health-related quality of life.Rabeprazole for the treatment of acid-related disorders.Gastroesophageal reflux and rhinosinusitis.Current pharmacological management of gastroesophageal reflux disease.Correlation Between Symptom Severity and Health-Related Life Quality of a Population With Gastroesophageal Reflux Disease.Neurophysiology and new techniques to assess esophageal sensory function: an update.Unmet treatment needs of gastroesophageal reflux disease in Asia: gastroesophageal reflux disease in Asia Pacific survey.Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.Clinical trial: esomeprazole for moderate-to-severe nighttime heartburn and gastro-oesophageal reflux disease-related sleep disturbances.Alginate antacid (Gaviscon DA) chewable tablets reduce esophageal acid exposure in Chinese patients with gastroesophageal reflux disease and heartburn symptoms.Characteristics of symptom presentation and risk factors in patients with erosive esophagitis and nonerosive reflux disease.Sickness absence due to gastroesophageal reflux diagnoses: a nationwide Swedish population-based study.The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms.Quality of life, patient satisfaction, and disease burden in patients with gastroesophageal reflux disease with or without laryngopharyngeal reflux symptoms.Editorial: Novel imaging for endoscopic evaluation of gastroesophageal reflux disease: seeing is believing.Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persist vs resolve on medical therapy.The impact of COPD on quality of life, productivity loss, and resource use among the elderly United States workforce.Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: A post hoc analysis of the 2007 national health and wellness survey.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Validation of the oesophageal hypervigilance and anxiety scale for chronic oesophageal disease.
P2860
Q26765113-3DA865B6-EEAD-4AE9-9702-171DFFC1919EQ34039035-CE4000B4-26D7-4551-9861-AD730BDA88BEQ34105424-1E28B515-CF33-418D-B3B8-D5B9F3D9B420Q34168618-13170ADA-45D2-42A0-AFBB-D6FFF6BA10B8Q34375433-B8AF6354-28BD-4367-B8CE-DE657627DC52Q35003385-5D28D2EC-A4A2-43ED-98FA-88C4959506B5Q35209935-309F2318-A0CE-4C85-80A5-97F28B90B7EBQ35885164-48E59913-CC07-4C5D-A830-DA182F096A7CQ36803119-3CF8F89B-89F5-4C86-ADA2-2CECF7A0DAEAQ37067053-10E31F12-E5E0-4AB6-9388-426B91DF7F5EQ37172386-3C5C8F09-797E-47AB-A02A-463148C719B4Q37295956-879C0960-76FA-4C5C-AF98-54CF813017CCQ37300891-9139CC05-39E2-4F38-8E01-AE301B8521BBQ37405874-771A7147-B56E-4F1D-A0C0-2DA53388634CQ37466737-F3E2695B-9080-4778-A914-8198451FA144Q37595198-1AAF6573-2FD6-4F4B-891F-293A882E9962Q37681015-1D7DECF9-4636-4A83-A0F0-7447530CFCD2Q37947173-82B1C838-D3A1-45FE-85A9-A9DD8E3FFA41Q38001045-FE0D4B58-9576-46BA-AE82-37FE11998355Q38038691-5B91841A-7D84-4210-8113-506D96C04DCAQ38078261-0DD7627D-F5CE-48A3-A962-A8FA8AA541F5Q38123482-F582418D-C3E3-439F-BCDD-25F68FF48645Q38790701-4586D7B7-154E-450D-A925-043D6B3CB9C2Q38947123-799B1C7C-0896-488D-A64D-EF4573A3368AQ39204530-0E2C4494-848F-417A-B81B-BD6A5FEB43FDQ39212872-11876AC1-656D-4A69-8874-3814AAB9E6F3Q39286111-E2916028-8FDC-40A6-A1C9-1B14EE8D311EQ39396442-3CD14BDE-DE8B-49B6-892B-E2A5BC213C23Q42759309-6AC889F9-260B-4B94-A944-4A08D27489F2Q43742978-CCAD02BA-82C6-4AC5-8CC7-5FFAAAD1A33FQ44933718-AEF92EEF-1DDF-4770-AF2B-544F2FB3E0BEQ47594826-E7B5B8EC-0900-421E-96E7-5F7951DDE5BBQ47665565-9506B754-6605-4AD6-9668-B0A6E3320016Q48083848-C1A4B13D-09CD-4886-8974-F70D28B9FA06Q48489640-522D7739-DB8C-43D5-9FDC-A87FC2FE210FQ48629907-6ADB3685-93B5-4A40-AED5-980E7D99F40FQ50129556-594E3CB6-2443-4183-A1B7-3A9D25631DBDQ52661254-7CD55407-C572-4ACC-8B55-397AE7A3240D
P2860
Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Relationship between symptom l ...... seases: survey of a US cohort.
@en
Relationship between symptom l ...... seases: survey of a US cohort.
@nl
type
label
Relationship between symptom l ...... seases: survey of a US cohort.
@en
Relationship between symptom l ...... seases: survey of a US cohort.
@nl
prefLabel
Relationship between symptom l ...... seases: survey of a US cohort.
@en
Relationship between symptom l ...... seases: survey of a US cohort.
@nl
P2093
P1476
Relationship between symptom l ...... seases: survey of a US cohort.
@en
P2093
J Carlsson
M Karlsson
M-A Wallander
P Wahlqvist
P304
P356
10.1111/J.1365-2036.2008.03671.X
P407
P577
2008-02-29T00:00:00Z